| Datum | Källa | Rubrik | Typ | Alternativ |
|---|---|---|---|---|
| 2024-05-16 | Redeye | Redeye: GenovisQ1 2024 - Financials in line with expectations, strong outlook | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Genovis | Communiqué from Genovis AB (publ) Annual General Meeting May 15, 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Genovis | Kommuniké från Årsstämman i Genovis AB (publ) den 15 maj 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Genovis | Genovis AB: Interim Report January - March 2024 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Genovis | Genovis AB: Kvartalsrapport januari - mars 2024 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-24 | Genovis | Genovis AB: Genovis Annual Report 2023 published | Pressreleaser | Ladda ner | Visa Stäng |
|
Pressreleaser |
Genovis AB: Genovis Annual Report 2023 publishedTo read or download the annual report in Swedish, go to: https://investor.genovis.com/wp-content/uploads/Genovis_AR_2023_Sv.pdf To read or download the annual report in English, go to: https://investor.genovis.com/wp-content/uploads/Genovis_AR_2023_En.pdf For more information, please contact: Fredrik Olsson, CEO, Genovis AB T+46 (0)70 276 46 56 E: |
||||
| 2024-04-24 | Genovis | Genovis AB: Genovis årsredovisning 2023 publicerad | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-09 | Genovis | Genovis AB: KALLELSE TILL ÅRSSTÄMMA 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-09 | Genovis | Genovis AB: NOTICE CONVENING THE 2024 ANNUAL GENERAL MEETING | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-14 | Genovis | Genovis AB: Carthesian Therapeutics terminates Genovis Licence Agreement | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-14 | Genovis | Genovis AB: Cartesian Therapeutics säger upp licensavtal med Genovis | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-19 | Redeye | Redeye: Genovis Q4 2023 - Soft ending but promising start | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-15 | Genovis | Genovis AB: Bokslutskommuniké januari-december 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-15 | Genovis | Genovis AB: Year-end report January-December 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-13 | Genovis | Genovis AB: Genovis to receive USD 1 million in milestone compensation related to the development of the Xork™ enzyme | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-13 | Genovis | Genovis AB: Genovis erhåller 1 miljon USD i milstolpsersättning relaterat till utvecklingen av Xork™-enzymet | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | Genovis | Genovis AB byter Certified Adviser till Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | Genovis | Genovis AB changes Certified Adviser to Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-16 | Redeye | Redeye: Genovis Q3 2023 - Solid growth and profitability, Xork timeline remains on track | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-15 | Genovis | Genovis AB: Delårsrapport januari-september 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-15 | Genovis | Genovis AB: Interim Report January-September 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-25 | Redeye | Redeye: Genovis Q2 2023 - Strong growth and expanding EBIT margin | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-24 | Genovis | Genovis AB: Halvårsrapport januari-juni 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-24 | Genovis | Genovis AB: Half-Yearly Report January-June 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
Kommande händelser